Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jiangxue Hou"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Targeted Protein Degradation (TPD) represented by Proteolysis-Targeting Chimeras (PROTAC) is the frontier field in the research and development of antitumor therapy, in which oral drug HP518 Receives FDA Proceed Authorization for its IND Application
Externí odkaz:
https://doaj.org/article/69b79d6e2cb74a5593b7dd1c9fce8fd4
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/8daf6070a7af4090b30da95364528ac5
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-3 (2023)
Abstract Bispecific antibodies (BsAbs) and dual-targeted chimeric antigen receptor T (CAR T) cells have been employed in relapsed/refractory multiple myeloma (RRMM) patients over the past few years, as an increasing number of patients were ineffectiv
Externí odkaz:
https://doaj.org/article/07e5b6f9ac4e4ab8aa4234f2ad3677f2
Autor:
Yang Song, Jiangxue Hou, Li Wan, Kaiqi Liu, Chunlin Zhou, Shuning Wei, Guangji Zhang, Dong Lin, Yan Li, Qiuyun Fang, Yuntao Liu, Benfa Gong, Xiaoyuan Gong, Ying Wang, Hui Wei, Jianxiang Wang, Yingchang Mi
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 518-522 (2022)
Background Resembling acute promyelocytic leukemia (APL) is a unique subtype of APL who sharing clinical, morphological, and immunophenotypic features with typical APL, but lacking evidence of PML-RARA fusion gene and usually insensitive to arsenic t
Externí odkaz:
https://doaj.org/article/7d3af18eb28349a89da3d35922c9aab3
Autor:
Qishan Hao, Yang Song, Qiuyun Fang, Zhe Wang, Shuning Wei, Guangji Zhang, Jiangxue Hou, Zheng Tian, Erlie Jiang, Jianxiang Wang, Yingchang Mi
Publikováno v:
Blood. 140:11517-11518